SEC Form 4 · accession 0001534424-17-000415
ClearPoint Neuro, Inc. · CLPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wendelin C Maners
Officer — Vice President, Marketing
Period of report
Oct 4, 2017
Accepted (ET)
Oct 5, 2017 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001285550
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 4, 2017 | A | 8,503 | $0.00 | A | 38,900 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F2 | $2.60 | Oct 4, 2017 | A | 1,875 | A | — | Oct 4, 2027 | Common Stock | 1,875 | 1,875 | D |
| Stock Options (right to buy)F3 | $2.60 | Oct 4, 2017 | A | 20,000 | A | — | Oct 4, 2027 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The Reporting Person received a portion of her 2016 cash bonus in the form of the Company's common stock based on the closing sales price of the Company's common stock on October 4, 2017. The shares were granted under the Company's Second Amended and Restated 2013 Incentive Compensation Plan.
- F2The shares subject to this option vest ratably in three equal installments on December 1, 2017, December 1, 2018 and December 1, 2019.
- F3The shares subject to this option vest as follows: (i) one-third of the total shares on the first anniversary of the grant date; and (ii) the remaining two-thirds of the total shares ratably on a monthly basis over the 24-month period immediately following the first anniversary of the grant date.